IMUNON announces the addition of Sachet A. Shukla, Ph.D. to the company’s scientific advisory board. Dr. Shukla is Assistant Professor, Department of Hematopoietic Biology and Malignancy, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center. He joins current advisory board members Dan H. Barouch, M.D., Ph.D., John W. Shiver, Ph.D., and Luke D. Handke, Ph.D.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IMNN:
- Imunon reports Q2 EPS (61c) vs. (87c) last year
- Imunon announces data on PlaCCine vaccines
- Preclinical Data Showing Strong Immunogenicity and Protection with IMUNON’s PlaCCine DNA-Based Vaccines Modality Available Online on bioRxiv
- IMUNON to Hold Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 10, 2023
- IMUNON Unveils New Manufacturing Capabilities at Huntsville’s HudsonAlpha Biotech Campus
